{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:53:45Z","timestamp":1761490425492,"version":"build-2065373602"},"reference-count":70,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Human African Trypanosomiasis (HAT), a disease that provokes 2184 new cases a year in Sub-Saharan Africa, is caused by Trypanosoma brucei. Current treatments are limited, highly toxic, and parasite strains resistant to them are emerging. Therefore, there is an urgency to find new drugs against HAT. In this context, T. brucei depends on glycolysis as the unique source for ATP supply; therefore, the enzyme triosephosphate isomerase (TIM) is an attractive target for drug design. In the present work, three new benzimidazole derivatives were found as TbTIM inactivators (compounds 1, 2 and 3) with an I50 value of 84, 82 and 73 \u00b5M, respectively. Kinetic analyses indicated that the three molecules were selective when tested against human TIM (HsTIM) activity. Additionally, to study their binding mode in TbTIM, we performed a 100 ns molecular dynamics simulation of TbTIM-inactivator complexes. Simulations showed that the binding of compounds disturbs the structure of the protein, affecting the conformations of important domains such as loop 6 and loop 8. In addition, the physicochemical and drug-like parameters showed by the three compounds suggest a good oral absorption. In conclusion, these molecules will serve as a guide to design more potent inactivators that could be used to obtain new drugs against HAT.<\/jats:p>","DOI":"10.3390\/molecules22122055","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T06:39:25Z","timestamp":1511505565000},"page":"2055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Species-Specific Inactivation of Triosephosphate Isomerase from Trypanosoma brucei: Kinetic and Molecular Dynamics Studies"],"prefix":"10.3390","volume":"22","author":[{"given":"Alejandra","family":"V\u00e1zquez-Raygoza","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Nutrition, Juarez University of Durango State, Av. Universidad y Fanny Anitua S\/N, Durango 34000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Cano-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Vel\u00e1zquez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Trejo-Soto","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Castillo","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Hern\u00e1ndez-Campos","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Hern\u00e1ndez-Luis","sequence":"additional","affiliation":[{"name":"School of Chemistry, Pharmacy Department, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-1879","authenticated-orcid":false,"given":"Jes\u00fas","family":"Oria-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Biochemistry and Genetics Laboratory, National Institute of Pediatrics, Ministry of Health, Mexico City 04534, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Castillo-Villanueva","sequence":"additional","affiliation":[{"name":"Biochemistry and Genetics Laboratory, National Institute of Pediatrics, Ministry of Health, Mexico City 04534, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Avitia-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Nutrition, Juarez University of Durango State, Av. Universidad y Fanny Anitua S\/N, Durango 34000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Sierra-Campos","sequence":"additional","affiliation":[{"name":"Faculty of Chemical Sciences, Juarez University of Durango State, Av. Art\u00edculo 123 S\/N Fracc. Filadelfia, Gomez Palacio, Durango 35010, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Valdez-Solana","sequence":"additional","affiliation":[{"name":"Faculty of Chemical Sciences, Juarez University of Durango State, Av. Art\u00edculo 123 S\/N Fracc. Filadelfia, Gomez Palacio, Durango 35010, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-4111","authenticated-orcid":false,"given":"Alfredo","family":"T\u00e9llez-Valencia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Nutrition, Juarez University of Durango State, Av. Universidad y Fanny Anitua S\/N, Durango 34000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"ref_1","unstructured":"W.H.O. (2017, September 17). Trypanosomiasis, Human African (Sleeping Sickness), Epidemiological Situation. Available online: http:\/\/www.who.int\/trypanosomiasis_african\/country\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: Current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2006.09.003","article-title":"Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960\u20131995 and 1999\u20132004","volume":"100","author":"Likeufack","year":"2006","journal-title":"Acta Trop."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actatropica.2007.07.007","article-title":"Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate","volume":"104","author":"Maina","year":"2007","journal-title":"Acta Trop."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"Delespaux","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/EC.00200-09","article-title":"Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes","volume":"9","author":"Stewart","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Graf, F.E., Ludin, P., Wenzler, T., Kaiser, M., Brun, R., Pyana, P.P., B\u00fcscher, P., De Koning, H.P., Horn, D., and M\u00e4ser, P. (2013). Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002475"},{"key":"ref_8","unstructured":"World Health Organization (WHO) (2017, September 17). Control and Surveillance of Human African Trypanosomiasis: Report of a WHO Expert Committee. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/42087\/1\/WHO_TRS_881.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"28306","DOI":"10.1074\/jbc.M502403200","article-title":"Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei","volume":"280","author":"Albert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bj3570117","article-title":"Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei","volume":"357","author":"Helfert","year":"2001","journal-title":"Biochem. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/bi0522293","article-title":"Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor","volume":"45","author":"Costas","year":"2006","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbiopara.2010.01.002","article-title":"An internal sequence targets Trypanosoma brucei triosephosphate isomerase to glycosomes","volume":"171","author":"Galland","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0169-4758(96)10073-9","article-title":"Metabolic compartmentation in African trypanosomes","volume":"12","author":"Clayton","year":"1996","journal-title":"Parasitol. Today"},{"key":"ref_14","first-page":"231","article-title":"Probing the catalytic sites of triosephosphate isomerase by 31P-NMR with reversibly and irreversibly binding substrate analogues","volume":"199","author":"Schnackerz","year":"1991","journal-title":"FEBS J."},{"key":"ref_15","first-page":"5189","article-title":"Structural determinants for ligand binding and catalysis of triosephosphate isomerase","volume":"268","author":"Kursula","year":"2001","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-2836(91)90368-G","article-title":"Refined 1.83 \u00c5 structure of trypanosomal triosephosphate isomerase crystallized in the presence of 2.4 M-ammonium sulphate: A comparison with the structure of the trypanosomal triosephosphate isomerase-glycerol-3-phosphate complex","volume":"220","author":"Wierenga","year":"1991","journal-title":"J. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0006-291X(02)00796-9","article-title":"Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi","volume":"295","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/bi0206560","article-title":"Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers","volume":"42","year":"2003","journal-title":"Biochemistry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1016\/j.bmcl.2009.08.055","article-title":"Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose","volume":"19","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_20","first-page":"441","article-title":"Inhibition of triosephosphate isomerase from Trypanosoma brucei with cyclic hexapeptides","volume":"207","author":"Kuntz","year":"1992","journal-title":"FEBS J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/14756366.2013.765415","article-title":"New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: A deeper insight into the mechanism of inhibition","volume":"29","author":"Alvarez","year":"2014","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","article-title":"The therapeutic journey of benzimidazoles: A review","volume":"20","author":"Bansal","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1016\/j.bmcl.2004.04.051","article-title":"Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation","volume":"14","author":"Hong","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1016\/j.bmc.2008.02.077","article-title":"Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class","volume":"16","author":"Kaynak","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/14756360802694427","article-title":"Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles","volume":"24","author":"Sharma","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14756360802632716","article-title":"Microwave assisted, one-pot synthesis of 5-nitro-2-aryl substituted-1H-benzimidazole libraries: Screening in vitro for antimicrobial activity","volume":"24","author":"Hosamani","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.ejmech.2011.06.006","article-title":"Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents","volume":"46","author":"Abonia","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bmcl.2010.02.053","article-title":"Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents","volume":"20","author":"Miller","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2017.05.058","article-title":"Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds","volume":"137","author":"Castillo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.bmcl.2013.05.081","article-title":"Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents","volume":"23","author":"Kwak","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1016\/j.bmcl.2013.10.011","article-title":"Synthesis and antiprotozoal activity of nitazoxanide\u2013N-methylbenzimidazole hybrids","volume":"23","author":"Maldonado","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.bmcl.2014.10.017","article-title":"A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis","volume":"24","author":"Castillo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4155\/fmc.13.173","article-title":"Chemoinformatic characterization of activity and selectivity switches of antiprotozoal compounds","volume":"6","author":"Castillo","year":"2014","journal-title":"Future Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.rvsc.2016.02.006","article-title":"Proteomic and ultrastructural analysis of the effect of a new nitazoxanide-N-methyl-1H-benzimidazole hybrid against Giardia intestinalis","volume":"105","author":"Castillo","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bmcl.2016.12.004","article-title":"Novel triclabendazole prodrug: A highly water soluble alternative for the treatment of fasciolosis","volume":"27","author":"Castillo","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jmgm.2011.06.009","article-title":"The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: A problem of residue motility","volume":"30","author":"Castillo","year":"2011","journal-title":"J. Mol. Graph. Model."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1590\/0074-0276140096","article-title":"JVG9, a benzimidazole derivative, alters the surface and cytoskeleton of Trypanosoma cruzi bloodstream trypomastigotes","volume":"109","author":"Castillo","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1016\/j.bmcl.2015.08.018","article-title":"Synthesis and trypanocidal activity of novel benzimidazole derivatives","volume":"26","author":"Castillo","year":"2016","journal-title":"Eur. J. Med. Chem. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1021\/bi00364a039","article-title":"Inactivation of Escherichia coli glycerol kinase by 5,5\u2032-dithiobis (2-nitrobenzoic acid) and N-ethylmaleimide: Evidence for nucleotide regulatory binding sites","volume":"25","author":"Pettigrew","year":"1986","journal-title":"Biochemistry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/14756366.2012.700928","article-title":"1,2,4-thiadiazol-5(4H)-ones: A new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition","volume":"28","author":"Alvarez","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jmgm.2015.02.002","article-title":"Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity","volume":"58","author":"Minini","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bpj.2015.06.031","article-title":"How an inhibitor bound to subunit interface alters triosephosphate isomerase dynamics","volume":"109","author":"Kurkcuoglu","year":"2015","journal-title":"Biophys. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jmb.2004.06.056","article-title":"Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface","volume":"341","author":"Costas","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1016\/j.bmcl.2004.04.013","article-title":"Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design","volume":"14","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbrc.2005.01.043","article-title":"Structural considerations for the rational design of selective anti-trypanosomal agents: The role of the aromatic clusters at the interface of triosephosphate isomerase dimer","volume":"328","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/znc-1980-11-1224","article-title":"Folding and association of triose phosphate isomerase from rabbit muscle","volume":"35","author":"Zabori","year":"1980","journal-title":"Z. Naturforsch. C"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/bi00465a005","article-title":"Stabilization of a reaction intermediate as a catalytic device: Definition of the functional role of the flexible loop in triosephosphate isomerase","volume":"29","author":"Pompliano","year":"1990","journal-title":"Biochemistry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0969-2126(01)00202-7","article-title":"Three new crystal structures of point mutation variants of mono TIM: Conformational flexibility of loop-1, loop-4 and loop-8","volume":"3","author":"Borchert","year":"1995","journal-title":"Structure"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/protein\/gzp005","article-title":"Detection of the protein dimers, multiple monomeric states and hydrated forms of Plasmodium falciparum triosephosphate isomerase in the gas phase","volume":"22","author":"Thakur","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/protein\/gzn002","article-title":"Structure-based protein engineering efforts with a monomeric TIM variant: The importance of a single point mutation for generating an active site with suitable binding properties","volume":"21","author":"Alahuhta","year":"2008","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/bi9002887","article-title":"The role of loop-loop interactions in coordinating motions and enzymatic function in triosephosphate isomerase","volume":"48","author":"Wang","year":"2009","journal-title":"Biochemistry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s00018-010-0473-9","article-title":"Triosephosphate isomerase: A highly evolved biocatalyst","volume":"67","author":"Wierenga","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1021\/bi500458t","article-title":"Enzyme architecture: The effect of replacement and deletion mutations of loop 6 on catalysis by triosephosphate isomerase","volume":"53","author":"Zhai","year":"2014","journal-title":"Biochemistry"},{"key":"ref_54","first-page":"703","article-title":"Overexpression of trypanosomal triosephosphate isomerase in Escherichia coli and characterisation of a dimer-interface mutant","volume":"211","author":"Borchert","year":"1993","journal-title":"FEBS J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014A rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15483","DOI":"10.1021\/bi061683j","article-title":"Functional role of the conserved active site proline of triosephosphate isomerase","volume":"45","author":"Casteleijn","year":"2006","journal-title":"Biochemistry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: A tool for high-throughput crystallography of protein-ligand complexes","volume":"60","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_60","first-page":"397","article-title":"The GROMOS software package for biomolecular simulations","volume":"95","author":"Scott","year":"1995","journal-title":"METECC"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1110\/ps.062323407","article-title":"Molecular dynamics simulations of the native and partially folded states of ubiquitin: Influence of methanol cosolvent, pH, and temperature on the protein structure and dynamics","volume":"16","author":"Kony","year":"2007","journal-title":"Protein Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1080\/00268978800101881","article-title":"An analysis of the accuracy of Langevin and molecular dynamics algorithms","volume":"65","author":"Pastor","year":"1988","journal-title":"Mol. Phys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/protein\/7.3.385","article-title":"A new method for predicting binding affinity in computer-aided drug design","volume":"7","author":"Medina","year":"1994","journal-title":"Protein Eng."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1016\/j.ejmech.2010.09.008","article-title":"Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations","volume":"45","author":"Punkvang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jmgm.2013.01.007","article-title":"Towards the identification of the binding site of benzimidazoles to \u03b2-tubulin of Trichinella spiralis: Insights from computational and experimental data","volume":"41","author":"Castillo","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"ref_69","unstructured":"(2017, July 20). Faf-Drugs4 Server. Available online: http:\/\/fafdrugs3.mti.univ-paris-diderot.fr\/."},{"key":"ref_70","unstructured":"(2017, July 20). PROTOX\u2014Prediction of Rodent Oral TOXicity. Available online: http:\/\/tox.charite.de\/tox\/."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/12\/2055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:51:09Z","timestamp":1760208669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/12\/2055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["molecules22122055"],"URL":"https:\/\/doi.org\/10.3390\/molecules22122055","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}